ROTEM® sigma

Combining innovation with experience

ROTEM® sigma provides rapid haemostasis information in critically ill patient care.*

Proven technology. Fully automated.

ROTEM® sigma offers the cutting-edge combination of innovative automated functionality with accredited proven ROTEM® technology. The ROTEM® sigma is a closed system, easy-to-use:

  • Fully automated – pipetting and test preparation not required
  • Sample vial fits directly into cartridge to avoid blood handling
  • Simplistic cartridge system that minimises operator involvement
  • Runs automated functionality checks before every measurement
  • Existing algorithms, recommendations, guidelines and literature are applicable
ROTEM-freigestellta

ROTEM® sigma – Smooth and easy-to-use

ROTEM® sigma  offers rapid, accurate test results in just a few simple steps:

  • Pipetting and test preparation not required
  • Sample vial fits directly into cartridge to avoid direct blood contact

Technology you can trust.

Vollautomatisiert

Fully automated

  • Pipetting and test preparation not required
Smart-und-schnell

Smart and fast

  • Especially EXTEM C and FIBTEM C tests
  • Cartridges can be stored at room temperature
  • Time to first results (e.g. A5): 7-9 min
Einfache-und-sichere-Bedienung

Easy and safe

  • Sample vial fits directly to cartridge to avoid blood handling
  • Control management system for reagents
  • Functionality checks before every measurement
Bewährte-Technologie

Proven technology

  • Existing algorithms, recommendations, guidelines and literature are applicable
Etablierte-Interpretation

Established interpretation

  • Result interpretation through characteristic color-coded TEMograms

ROTEM® sigma cartridges: rapid, accurate test results when time is crucial

Both ROTEM® sigma cartridges:

 

  • Detect factor deficiency
  • Discriminate between thrombocytopenia and fibrinogen deficiency or fibrin polymerization disorders
  • Detect hyperfibrinolysis
  • Detect direct FX inhibitors and direct thrombin (FIIa) inhibitor effects
Testpanel sigma comp
  • Discrimination between hyperfibrinolysis and clot retraction/FXIII deficiency
  • In vitro assessment of the effect of antifibrinolytic drugs
Testpanel sigma comp + hep
  • Detection of heparin and heparin-like substances
  • Discrimination between factor deficiency and heparin effect
  • Suited for application in cardiac and vascular surgery

Further advantages and product details

The economic and the clinical effectiveness of ROTEM®-diagnostic was demonstrated in clinical studies and health technology assessments. This resulted in recommendations: ESA guideline, ASA guideline,  NICE recommendation, PPH guidance of the SSC ISTH and European Trauma Guideline.

Last Modified: